可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Morrow JD. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans [J]. Arterioscler Thromb Vasc Biol, 2005, 25(2):279-286.
[2] Kobayashi N, DeLano FA, SchmidSchonbein GW. Oxidative stress promotes endothelial cell apoptosis and loss of microvessels in the spontaneously hypertensive rats[J]. Arterioscler Thromb Vasc Biol, 2005, 25(10):2114-2121.
[3] Virdis A, Neves MF, Amiri F, et al. Role of NAD (P) H oxidase on vascular alterations in angiotensin IIinfused mice[J]. J Hypertens, 2004, 22(3):535-542.
[4] Wang B, Pan J, Wang L, et al. Associations of plasma 8isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease[J]. Atherosclerosis, 2006, 184(2):425-430.
[5] Nobecourt E, Jacqueminet S, Hansel B, et al. Defective antioxidative activity of small dense HDL 3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia[J]. Diabetologia, 2005, 48(2):529-538.
[6] Flores L, Rodela S, Abian J, et al. F2 isoprostane is already increased at the onset of type 1 diabetes mellitus: effect of glycemic control[J]. Metabolism, 2004, 53(9):1118-1120.
[7] 郑莺, 刘建平. 糖尿病致冠状动脉硬化的机制[J]. 心脏杂志, 2007, 19(3):347-350.
[8] Brownlee M. The pathobiology of diabetic complications: a unifying mechanism[J]. Diabetes, 2005, 54(6):1615-1625.
[9] Oberg BP, McMenamin E, Lucas FL, et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease[J]. Kidney Int, 2004, 65(3):1009-1016.
[10]Dobrian AD, Schriver SD, Khraibi AA, et al. Pioglitazone prevents hypertension and reduces oxidative stress in dietinduced obesity[J]. Hypertension, 2004, 43(1):48-56.
[11]Poirier P, Giles TD, Bray GA. Obesity and cardiovascular disease: pathophysiology, evaluation and effect of weight loss[J]. Arterioscler Thromb Vasc Biol, 2006, 26(5):968-976.
[12]Shin MJ, Lee JH, Jang Y, et al. Insulin resistance, adipokines, and oxidative stress in nondiabetic, hypercholesterolemic patients:leptin as an 8epiprostaglandin F2alpha determinant[J]. Metabolism, 2006, 55(7):918-922.
[13]王秋林, 王浩毅, 王树人. 氧化应激状态的评价[J]. 中国病理生理杂志, 2005, 21(10):2069-2074.